QTcF prolongation in healthy volunteer MAD cohort 3 (MAD3; 100 mg) and in open-label HS/AD patient cohort.
ATOPIC DERMATITIS, HIDRADENITIS SUPPURATIVA
Mean change from baseline (ΔQTcF) and absolute QTcF values are shown at the indicated time points for MAD3 (100 mg daily fasted x 14 days, n = 9) and open-label patient cohort (75 mg daily fed x 28 days, n = 20). AD = atopic dermatitis; CI = confidence interval; HS = hidradenitis suppurativa; MAD = multiple ascending doses; QTcF = corrected QT interval by Fredericia.

